These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 8493863)

  • 1. The topographic distribution of brain atrophy in Huntington's disease and progressive supranuclear palsy.
    Mann DM; Oliver R; Snowden JS
    Acta Neuropathol; 1993; 85(5):553-9. PubMed ID: 8493863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.
    de la Monte SM; Vonsattel JP; Richardson EP
    J Neuropathol Exp Neurol; 1988 Sep; 47(5):516-25. PubMed ID: 2971785
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.
    Boxer AL; Geschwind MD; Belfor N; Gorno-Tempini ML; Schauer GF; Miller BL; Weiner MW; Rosen HJ
    Arch Neurol; 2006 Jan; 63(1):81-6. PubMed ID: 16401739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional specificity of brain atrophy in Huntington's disease.
    Halliday GM; McRitchie DA; Macdonald V; Double KL; Trent RJ; McCusker E
    Exp Neurol; 1998 Dec; 154(2):663-72. PubMed ID: 9878201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal analysis of regional grey matter loss in Huntington disease: effects of the length of the expanded CAG repeat.
    Ruocco HH; Bonilha L; Li LM; Lopes-Cendes I; Cendes F
    J Neurol Neurosurg Psychiatry; 2008 Feb; 79(2):130-5. PubMed ID: 17615168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical deficits correlate with regional cerebral atrophy in progressive supranuclear palsy.
    Cordato NJ; Duggins AJ; Halliday GM; Morris JG; Pantelis C
    Brain; 2005 Jun; 128(Pt 6):1259-66. PubMed ID: 15843423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The topographic distribution of brain atrophy in Alzheimer's disease.
    Mann DM
    Acta Neuropathol; 1991; 83(1):81-6. PubMed ID: 1792867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early atrophy of pallidum and accumbens nucleus in Huntington's disease.
    van den Bogaard SJ; Dumas EM; Acharya TP; Johnson H; Langbehn DR; Scahill RI; Tabrizi SJ; van Buchem MA; van der Grond J; Roos RA;
    J Neurol; 2011 Mar; 258(3):412-20. PubMed ID: 20936300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling trajectories of regional volume loss in progressive supranuclear palsy.
    Josephs KA; Xia R; Mandrekar J; Gunter JL; Senjem ML; Jack CR; Whitwell JL
    Mov Disord; 2013 Jul; 28(8):1117-24. PubMed ID: 23568852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional brain atrophy in progressive supranuclear palsy and Lewy body disease.
    Cordato NJ; Halliday GM; Harding AJ; Hely MA; Morris JG
    Ann Neurol; 2000 Jun; 47(6):718-28. PubMed ID: 10852537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study.
    Douaud G; Gaura V; Ribeiro MJ; Lethimonnier F; Maroy R; Verny C; Krystkowiak P; Damier P; Bachoud-Levi AC; Hantraye P; Remy P
    Neuroimage; 2006 Oct; 32(4):1562-75. PubMed ID: 16875847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cortical atrophy differentiates Richardson's syndrome from the parkinsonian form of progressive supranuclear palsy.
    Schofield EC; Hodges JR; Macdonald V; Cordato NJ; Kril JJ; Halliday GM
    Mov Disord; 2011 Feb; 26(2):256-63. PubMed ID: 21412832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroimaging comparison of primary progressive apraxia of speech and progressive supranuclear palsy.
    Whitwell JL; Duffy JR; Strand EA; Machulda MM; Senjem ML; Gunter JL; Kantarci K; Eggers SD; Jack CR; Josephs KA
    Eur J Neurol; 2013 Apr; 20(4):629-37. PubMed ID: 23078273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grey matter volume loss is associated with specific clinical motor signs in Huntington's disease.
    Coppen EM; Jacobs M; van den Berg-Huysmans AA; van der Grond J; Roos RAC
    Parkinsonism Relat Disord; 2018 Jan; 46():56-61. PubMed ID: 29128164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The topographic distribution of brain atrophy in frontal lobe dementia.
    Mann DM; South PW
    Acta Neuropathol; 1993; 85(3):334-40. PubMed ID: 8460535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.
    Kipps CM; Duggins AJ; Mahant N; Gomes L; Ashburner J; McCusker EA
    J Neurol Neurosurg Psychiatry; 2005 May; 76(5):650-5. PubMed ID: 15834021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-based volumetry differentiates progressive supranuclear palsy from corticobasal degeneration.
    Gröschel K; Hauser TK; Luft A; Patronas N; Dichgans J; Litvan I; Schulz JB
    Neuroimage; 2004 Feb; 21(2):714-24. PubMed ID: 14980574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topographic investigation of brain atrophy in parkinsonism-dementia complex of Guam: a comparison with Alzheimer's disease and progressive supranuclear palsy.
    Oyanagi K; Makifuchi T; Ohtoh T; Ikuta F; Chen KM; Chase TN; Gajdusek DC
    Neurodegeneration; 1994 Dec; 3(4):301-4. PubMed ID: 7842300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of astrocytic plaques in the corticobasal degeneration brain and comparison with tuft-shaped astrocytes in the progressive supranuclear palsy brain.
    Hattori M; Hashizume Y; Yoshida M; Iwasaki Y; Hishikawa N; Ueda R; Ojika K
    Acta Neuropathol; 2003 Aug; 106(2):143-9. PubMed ID: 12732936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.